Global /United States /Healthcare /Drug Manufacturers - General /PKTX

ProtoKinetix, Inc.

PKTX

• OTCMKTS: PKTX • Delayed

0.0054USD 0%

As of 13 June 2026, ProtoKinetix, Inc. has a market cap of $2.21M USD, ranking #46984 globally and #5959 in the United States. It ranks #4157 in the Healthcare sector, and #1316 in the Drug Manufacturers - General industry.

Global Rank

46984

Country Rank

5959

Sector Rank

4157

Industry Rank

1316

Key Stats

Market Cap

$2.21MUSD

Enterprise Value

$2.21MUSD

EBITDA (TTM)

-$324.58KUSD

Net Income (TTM)

-$376.17KUSD

PB Ratio

8.8

Company Profile

Country (HQ)

United States

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Michael Guzzetta open_in_new

Employees

Founded

1999

Website

protokinetix.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	-6.9%	8%	-6.9%	-3.6%	-10%	-45%	-80%	-98%

News

Markets

Exchange	Ticker	Price	Quotes
OTC Markets (OTCMKTS / OTC) MIC: OTCM PRIMARY	PKTX ProtoKinetix Inc ISIN: US7437221002 Shares Out.: Shares Outstanding: 391.58M¹ Shares Float: 305.206M² TV: TradingView: OTC: PKTX SA: Stock Analysis: OTC: PKTX YF: Yahoo Finance: PKTX GF: Google Finance: OTCMKTS: PKTX BA: Barron's: PKTX MS: Morningstar: PINX: PKTX	0.0054 USD	TV: TradingView: OTC: PKTX SA: Stock Analysis: OTC: PKTX YF: Yahoo Finance: PKTX GF: Google Finance: OTCMKTS: PKTX BA: Barron's: PKTX MS: Morningstar: PINX: PKTX

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About ProtoKinetix, Inc.

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). Its AFGPs are used in various commercial applications comprising targeted health care solutions, as well as AAGPs are used for applications in ophthalmology, dermatology, transplants, and biomanufacturing areas. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was incorporated in 1999 and is based in Dalton, Ohio.

Similar Companies

Industry: Drug Manufacturers - General (United States)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 34M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 25M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 16M%	97.4	United States
Merck & Co., Inc. NYSE: MRK	$274.03B 12M%	15.1	United States
Pfizer Inc. NYSE: PFE	$149.38B 7M%	19.5	United States
Bristol-Myers Squibb Co. NYSE: BMY	$117.58B 5M%	16.8	United States

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 15M%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 13M%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 12M%	20.5	Switzerland
Novo Nordisk A/S CPH: NOVO-B	$181.82B 1.18T DKK 8M%	11.5	Denmark
Sanofi EPA: SAN	$110.1B 95.26B EUR 5M%	19.9	France
GSK plc LSE: GSK	$108.46B 80.96B GBP 5M%	14.6	United Kingdom

chevron_leftBack